Corcept Therapeutics reported $0.29 in EPS Earnings Per Share for its fiscal quarter ending in June of 2025.


Fiscal Calendar Actual Consensus Previous Date
FY2025Q3 Sep/2025 0.17 0.41 Oct/29 2025
FY2025Q2 Jun/2025 0.29 0.38 0.32 Jul/31 2025
FY2025Q1 Mar/2025 0.17 0.15 0.25 May/05 2025
FY2024Q4 Dec/2024 0.26 0.38 0.28 Feb/26 2025
FY2024Q3 Sep/2024 0.41 0.28 0.28 Oct/30 2024



Eps Change Date
Acadia Pharmaceuticals USD 0.16 0.05 Jun/2025
Alaunos Therapeutics USD -0.46 0.24 Dec/2024
ANI Pharmaceuticals USD 1.8 0.1 Jun/2025
Ardelyx USD -0.08 0.1 Jun/2025
Aurora Cannabis CAD -0.26 0.84 Jun/2025
BioMarin Pharmaceutical USD 1.44 0.31 Jun/2025
Bristol-Myers Squibb USD 1.46 0.34 Jun/2025
Canopy Growth CAD -0.22 0.89 Jun/2025
Corcept Therapeutics USD 0.29 0.12 Jun/2025
Eli Lilly USD 6.31 2.97 Jun/2025
J&J USD 2.77 0 Jun/2025
Knight Therapeutics CAD 0 0.02 Sep/2024
Merck USD 2.13 0.09 Jun/2025
Novartis USD 2.42 0.14 Jun/2025
Novartis USD 2.06 0.08 Jun/2025
Pacira USD 0.74 0.12 Jun/2025
Pfizer USD 0.78 0.14 Jun/2025
Supernus Pharmaceuticals USD 0.4 0.61 Jun/2025
TG Therapeutics USD 0.17 0.14 Jun/2025